iX Biopharma Ltd. | |
Stock Exchange | Singapore Exchange |
EPS |
SGD0.02 |
Market Cap |
SGD170.82 M |
Shares Outstanding |
644.59 M |
Public Float |
257.95 M |
Address |
1 Kim Seng Promenade, No. 14-01 Singapore CE 237994 Singapore |
Employees | - |
Website | http://www.ixbiopharma.com |
Updated | 07/08/2019 |
iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical and Chemical Analysis. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products. |